Five things for pharma marketers to know: Tuesday, February 7, 2023

Astella goes “aggressive” with new CEO appointment; AbbVie plans to lift $2 billion cap on deals; Biogen, Sage receive NDA from Food and Drug Administration for zuranolone.

Related Keywords

Kenji Yasukawa ,Richard Gonzalez ,Naoki Okamura , ,Endpoints News ,Executive Officer Richard Gonzalez ,Wall Street Journal ,